serum amyloid A



serum amyloid A

M1MM1R2RR2S3SS3F4FF4F5FF5S6SS6F7FF7L8LL8G9GG9E10EE10A11AA11F12FF12D13DD13G14GG14A15AA15R16RR16D17DD17M18MM18W19WW19R20RR20A21AA21Y22YY22S23SS23D24DD24M25MM25R26RR26E27EE27A28AA28N29NN29Y30YY30I31II31G32GG32S33SS33D34DD34K35KK35Y36YY36F37FF37H38HH38A39AA39R40RR40G41GG41N42NN42Y43YY43D44DD44A45AA45A46AA46K47KK47... and 58 more residue(s)...... and 58 more residue(s)

SMILES None
InChIKey None
Sequence MRSFFSFLGEAFDGARDMWRAYSDMREANYIGSDKYFHARGNYDAAKRGPGGVWAAEAISNARENIQRFFGRGAEDSLADQAANEWGRSGKDPNHFRPAGLPEKY

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections



No bioactivity data available.

serum amyloid A

M1MM1R2RR2S3SS3F4FF4F5FF5S6SS6F7FF7L8LL8G9GG9E10EE10A11AA11F12FF12D13DD13G14GG14A15AA15R16RR16D17DD17M18MM18W19WW19R20RR20A21AA21Y22YY22S23SS23D24DD24M25MM25R26RR26E27EE27A28AA28N29NN29Y30YY30I31II31G32GG32S33SS33D34DD34K35KK35Y36YY36F37FF37H38HH38A39AA39R40RR40G41GG41N42NN42Y43YY43D44DD44A45AA45A46AA46K47KK47... and 58 more residue(s)...... and 58 more residue(s)

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections



Compound is not listed as a drug.